Plain-English translation of NCT06924359 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking for early warning signs of Alzheimer's disease by examining your eyes and analyzing your blood. Researchers believe that changes in the eye and certain proteins in the blood may help detect Alzheimer's disease before memory problems become serious. The goal is to develop new, faster ways to identify who might be at risk so that treatment can start earlier.
Alzheimer's disease is becoming more common as people live longer, but right now there's no reliable way to catch it in its earliest stages when treatment might work best. This study is trying to find simple tests—looking at the eye and checking blood markers—that could help doctors identify Alzheimer's much sooner.
You likely qualify if…
You likely don't qualify if…
You would visit the research clinic for evaluations that include memory and thinking tests, specialized eye imaging scans, and a blood draw. The study compares people at different stages—from those with no memory problems to those with Alzheimer's disease—to see if eye and blood patterns differ between groups. Your participation helps researchers understand whether these tests could become standard tools for early detection.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China
Sponsor
Peking University First Hospital
Enrollment target
~200 participants
Started
March 2025
Primary completion
August 2027
Age range
50 Years and older
Last updated on clinicaltrials.gov in April 2025.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.